NEW DIHYDROFOLATE REDUCTASE AND MODIFIED DIHYDROFOLATE REDUCTASE GENE

    公开(公告)号:JPH05146291A

    公开(公告)日:1993-06-15

    申请号:JP33623691

    申请日:1991-11-26

    Abstract: PURPOSE:To obtain the subject enzyme capable of suppressing inactivation of the enzyme and providing a homogenous immobilized enzyme having high activity by transducing an amino acid sequence containing plural amino acid residues having cysteine residue as the carboxyl terminal into the carboxyl terminal side of an enzymic protein. CONSTITUTION:A genetic DNA capable of coding a dihydrofolate reductase is used to replace the sequence part capable of coding the carboxyl terminal side of this enzymic protein with a chemical synthetic DNA. Thereby, a genetic DNA capable of coding a modified enzymic protein in which a short amino acid sequence is transduced so that the carboxyl terminal may be the cysteine residue is prepared. The resultant genetic DNA is then integrated into a vector such as a plasmid for expression to construct an expression vector, which is subsequently transduced into a host such as Escherichia coli and expressed. The obtained modified enzymic protein can be separated and purified from the host microbial cell to afford a new dihydrofolate reductase, having an amino acid sequence expressed by the formula, capable of efficiently producing a homogenous immobilized enzyme having high activity and utilizable for producing various useful substances.

    GROWTH HORMONE-RELEASING FACTOR DERIVATIVE

    公开(公告)号:JPH02258799A

    公开(公告)日:1990-10-19

    申请号:JP7946289

    申请日:1989-03-30

    Abstract: NEW MATERIAL:A dihydrofolate reductase-growth hormone-releasing factor derivative fused protein produced by Escherichia coli containing recombinant pGRF2-15. USE:An agent for fermentation, stock raising and drugs having bovine growth hormone-releasing factor and dihydrofolic acid reducing activity. PREPARATION:For example, recombinant plasmid pGRF2-15 containing a base sequence to code amino acid sequence of fused protein comprising dihydrofolate reductase-growth hormone-releasing factor shown by the formula is inserted into Escherichia coil, transformed, the transformant is cultured in a medium, the cell is ground, centrifuged, a fraction of supernatant liquid is collected and treated with streptomycin sulfate and ammonium sulfate to give an enzyme solution. The solution is purifying by using mesotrixate bonded affinity column chromatography to give growth hormone-releasing factor derivative.

    NOVEL RECOMBINANT PLASMID PDDM1
    26.
    发明专利

    公开(公告)号:JPH02142481A

    公开(公告)日:1990-05-31

    申请号:JP29551988

    申请日:1988-11-22

    Inventor: IWAKURA MASAHIRO

    Abstract: NEW MATERIAL:A recombinant plasmid pDDM1 having a DNA sequence expressed by the formula. USE:For producing dihydrofolate reductase. PREPARATION:For example, a plasmid pTP64-1 is cleaved with restriction enzymes BclI and BglII and then subjected to treatment with an alkaline phosphatase and phenol to denature and remove coexisting enzymic proteins. The resultant DNA is subsequently precipitated with ethanol and linked to a plasmid pTP70-1 cleaved with the restriction enzyme BglII using a T4-DNA ligase, inserted into Escherichia coli and the obtained transformant is then cultured to select a strain capable of producing dimer of dihydrofolate reductase(DHFR) from the formed colony. Thereby, the objective recombinant plasmid pDDM1 is obtained.

    NOVEL RECOMBINANT PLASMID PSG1-12
    27.
    发明专利

    公开(公告)号:JPH02138981A

    公开(公告)日:1990-05-28

    申请号:JP29338988

    申请日:1988-11-19

    Abstract: PURPOSE:To mass-produce a GRF1-29 derivative by forming a recombinant plasmid pSG1-12 having a DNA sequence coding a peptide fragment of GRF with a fused protein of dihydrofolate reductase. CONSTITUTION:A recombinant plasmid pSG1-12, stably replicative in Escherichia coli, capable of imparting tolerance to trimethoprim and ampicillin to Escherichia coli which is a host, coding a fused protein of a peptide fragment of a growth hormone releasing factor having a specific amino acid sequence and a dihydrofolate reductase and forming a recombinant plasmid and having a specific DNA sequence is formed. The recombinant plasmid encodes DHFR- GRFM and Escherichia coli having the pSG1-12 is capable of accumulating and producing the DHFR-GRFM in a large amount.

    ANGIOTENSIN I
    29.
    发明专利

    公开(公告)号:JPH01252287A

    公开(公告)日:1989-10-06

    申请号:JP7967888

    申请日:1988-03-31

    Abstract: PURPOSE:To obtain a large amount of dihydrofolic acid reductase-angiotensin fused protein, by manifesting a fused gene in which an angiotensin I gene is included in a recombined plasmid pLEK1 with a colon bacillus. CONSTITUTION:A newly recombined plasmid pANG1-23, which is replicated in stable with a colon bacillus, imparting resistance to trimethoprim and resistance to ampicillin to a colon bacillus as a host, having a size of 4222 basic pairs and having a replaced structure with a conformation of 28 basic pairs containing a conformation coding leucine enkephaline between BamHI site and MluI site in pLEK1 to a chemically synthesized DNA of 43 basic pairs containing a conformation coding angiotensin I, is produced. A colon bacillus introduced of pANG1-23 produces a large amount of dihydrofolic acid reductase- angiotensin fused protein.

Patent Agency Ranking